Fig. 6

Cell viability of SK-BR-3 human breast cancer cells after treatment by Art-NFs, Art@MSNs-NFs, and Art/Art@MSNs-NFs in 48 h. *p ≤ 05 versus pristine Art was considered significant. The data are presented as mean ± SD (n = 3)